Mirtazapine for chronic insomnia in older adults: weighing the risks and potential benefits

Joshua M. Inglis; Arduino A. Mangoni

doi:10.1093/ageing/afaf090

Mirtazapine for chronic insomnia in older adults: weighing the risks and potential benefits

Joshua M. Inglis
, Arduino A. Mangoni

College of Medicine and Public Health

Research output: Contribution to journal › Editorial

1 Citation (Scopus)

Abstract

Chronic insomnia is common in older adults and has a negative impact on functional status and quality of life [1]. Cognitive behavioural therapy (CBT) is the preferred treatment for chronic insomnia. However, delivering this to older adults can be challenging due to the limited availability of trained professionals as well as the time commitment and cost for patients.

Original language	English
Article number	afaf090
Number of pages	3
Journal	Age and Ageing
Volume	54
Issue number	4
DOIs	https://doi.org/10.1093/ageing/afaf090
Publication status	Published - Apr 2025

Keywords

adverse drug reactions
insomnia
mirtazapine
older adults
sleep

Access to Document

10.1093/ageing/afaf090Licence: In Copyright

Cite this

@article{9db39b6b97f84858b0a365234471e689,

title = "Mirtazapine for chronic insomnia in older adults: weighing the risks and potential benefits",

abstract = "Chronic insomnia is common in older adults and has a negative impact on functional status and quality of life [1]. Cognitive behavioural therapy (CBT) is the preferred treatment for chronic insomnia. However, delivering this to older adults can be challenging due to the limited availability of trained professionals as well as the time commitment and cost for patients.",

keywords = "adverse drug reactions, insomnia, mirtazapine, older adults, sleep",

author = "Inglis, \{Joshua M.\} and Mangoni, \{Arduino A.\}",

year = "2025",

month = apr,

doi = "10.1093/ageing/afaf090",

language = "English",

volume = "54",

journal = "Age and Ageing",

issn = "0002-0729",

publisher = "Oxford University Press",

number = "4",

}

TY - JOUR

T1 - Mirtazapine for chronic insomnia in older adults

T2 - weighing the risks and potential benefits

AU - Inglis, Joshua M.

AU - Mangoni, Arduino A.

PY - 2025/4

Y1 - 2025/4

N2 - Chronic insomnia is common in older adults and has a negative impact on functional status and quality of life [1]. Cognitive behavioural therapy (CBT) is the preferred treatment for chronic insomnia. However, delivering this to older adults can be challenging due to the limited availability of trained professionals as well as the time commitment and cost for patients.

AB - Chronic insomnia is common in older adults and has a negative impact on functional status and quality of life [1]. Cognitive behavioural therapy (CBT) is the preferred treatment for chronic insomnia. However, delivering this to older adults can be challenging due to the limited availability of trained professionals as well as the time commitment and cost for patients.

KW - adverse drug reactions

KW - insomnia

KW - mirtazapine

KW - older adults

KW - sleep

UR - https://www.scopus.com/pages/publications/105003278048

U2 - 10.1093/ageing/afaf090

DO - 10.1093/ageing/afaf090

M3 - Editorial

AN - SCOPUS:105003278048

SN - 0002-0729

VL - 54

JO - Age and Ageing

JF - Age and Ageing

IS - 4

M1 - afaf090

ER -

Mirtazapine for chronic insomnia in older adults: weighing the risks and potential benefits

Abstract

Keywords

Access to Document

Other files and links

Fingerprint

Cite this